Report Detail

Pharma & Healthcare Global (United States, European Union and China) Combined Hormonal Contraceptives Market Research Report 2019-2025

  • RnM3653182
  • |
  • 07 August, 2019
  • |
  • Global
  • |
  • 115 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Combined hormonal contraceptives are used to prevent pregnancies. They are also used in the treatment of acne vulgaris, endometriosis, polycystic ovarian syndrome, and irregular menstrual flow by blocking ovulation. These products are widely used by women of aged between 15 and 49 years.
In 2019, the market size of Combined Hormonal Contraceptives is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Combined Hormonal Contraceptives.

This report studies the global market size of Combined Hormonal Contraceptives, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Combined Hormonal Contraceptives sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Actavis
Agile Therapeutics
Allergan
Bayer
Teva Pharmaceutical Industries
ANI Pharmaceuticals
Ortho-McNeil-Janssen Pharmaceuticals
Noven Pharmaceuticals
Johnson & Johnson
Mylan

Market Segment by Product Type
15-24 years
25-34 years
35-44 years
Above 44 years

Market Segment by Application
Hospitals
Household
Clinics

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Combined Hormonal Contraceptives status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Combined Hormonal Contraceptives manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Combined Hormonal Contraceptives are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Combined Hormonal Contraceptives Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 15-24 years
      • 1.3.3 25-34 years
      • 1.3.4 35-44 years
      • 1.3.5 Above 44 years
    • 1.4 Market Segment by Application
      • 1.4.1 Global Combined Hormonal Contraceptives Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Household
      • 1.4.4 Clinics
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Combined Hormonal Contraceptives Market Size
      • 2.1.1 Global Combined Hormonal Contraceptives Revenue 2014-2025
      • 2.1.2 Global Combined Hormonal Contraceptives Sales 2014-2025
    • 2.2 Combined Hormonal Contraceptives Growth Rate by Regions
      • 2.2.1 Global Combined Hormonal Contraceptives Sales by Regions 2014-2019
      • 2.2.2 Global Combined Hormonal Contraceptives Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Combined Hormonal Contraceptives Sales by Manufacturers
      • 3.1.1 Combined Hormonal Contraceptives Sales by Manufacturers 2014-2019
      • 3.1.2 Combined Hormonal Contraceptives Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Combined Hormonal Contraceptives Revenue by Manufacturers (2014-2019)
      • 3.2.2 Combined Hormonal Contraceptives Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Combined Hormonal Contraceptives Market Concentration Ratio (CR5 and HHI)
    • 3.3 Combined Hormonal Contraceptives Price by Manufacturers
    • 3.4 Key Manufacturers Combined Hormonal Contraceptives Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Combined Hormonal Contraceptives Market
    • 3.6 Key Manufacturers Combined Hormonal Contraceptives Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 15-24 years Sales and Revenue (2014-2019)
      • 4.1.2 25-34 years Sales and Revenue (2014-2019)
      • 4.1.3 35-44 years Sales and Revenue (2014-2019)
      • 4.1.4 Above 44 years Sales and Revenue (2014-2019)
    • 4.2 Global Combined Hormonal Contraceptives Sales Market Share by Type
    • 4.3 Global Combined Hormonal Contraceptives Revenue Market Share by Type
    • 4.4 Combined Hormonal Contraceptives Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Combined Hormonal Contraceptives Sales by Application

    6 United States

    • 6.1 United States Combined Hormonal Contraceptives Breakdown Data by Company
    • 6.2 United States Combined Hormonal Contraceptives Breakdown Data by Type
    • 6.3 United States Combined Hormonal Contraceptives Breakdown Data by Application

    7 European Union

    • 7.1 European Union Combined Hormonal Contraceptives Breakdown Data by Company
    • 7.2 European Union Combined Hormonal Contraceptives Breakdown Data by Type
    • 7.3 European Union Combined Hormonal Contraceptives Breakdown Data by Application

    8 China

    • 8.1 China Combined Hormonal Contraceptives Breakdown Data by Company
    • 8.2 China Combined Hormonal Contraceptives Breakdown Data by Type
    • 8.3 China Combined Hormonal Contraceptives Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Combined Hormonal Contraceptives Breakdown Data by Company
    • 9.2 Rest of World Combined Hormonal Contraceptives Breakdown Data by Type
    • 9.3 Rest of World Combined Hormonal Contraceptives Breakdown Data by Application
    • 9.4 Rest of World Combined Hormonal Contraceptives Breakdown Data by Countries
      • 9.4.1 Rest of World Combined Hormonal Contraceptives Sales by Countries
      • 9.4.2 Rest of World Combined Hormonal Contraceptives Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Actavis
      • 10.1.1 Actavis Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Combined Hormonal Contraceptives
      • 10.1.4 Combined Hormonal Contraceptives Product Introduction
      • 10.1.5 Actavis Recent Development
    • 10.2 Agile Therapeutics
      • 10.2.1 Agile Therapeutics Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Combined Hormonal Contraceptives
      • 10.2.4 Combined Hormonal Contraceptives Product Introduction
      • 10.2.5 Agile Therapeutics Recent Development
    • 10.3 Allergan
      • 10.3.1 Allergan Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Combined Hormonal Contraceptives
      • 10.3.4 Combined Hormonal Contraceptives Product Introduction
      • 10.3.5 Allergan Recent Development
    • 10.4 Bayer
      • 10.4.1 Bayer Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Combined Hormonal Contraceptives
      • 10.4.4 Combined Hormonal Contraceptives Product Introduction
      • 10.4.5 Bayer Recent Development
    • 10.5 Teva Pharmaceutical Industries
      • 10.5.1 Teva Pharmaceutical Industries Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Combined Hormonal Contraceptives
      • 10.5.4 Combined Hormonal Contraceptives Product Introduction
      • 10.5.5 Teva Pharmaceutical Industries Recent Development
    • 10.6 ANI Pharmaceuticals
      • 10.6.1 ANI Pharmaceuticals Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Combined Hormonal Contraceptives
      • 10.6.4 Combined Hormonal Contraceptives Product Introduction
      • 10.6.5 ANI Pharmaceuticals Recent Development
    • 10.7 Ortho-McNeil-Janssen Pharmaceuticals
      • 10.7.1 Ortho-McNeil-Janssen Pharmaceuticals Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Combined Hormonal Contraceptives
      • 10.7.4 Combined Hormonal Contraceptives Product Introduction
      • 10.7.5 Ortho-McNeil-Janssen Pharmaceuticals Recent Development
    • 10.8 Noven Pharmaceuticals
      • 10.8.1 Noven Pharmaceuticals Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Combined Hormonal Contraceptives
      • 10.8.4 Combined Hormonal Contraceptives Product Introduction
      • 10.8.5 Noven Pharmaceuticals Recent Development
    • 10.9 Johnson & Johnson
      • 10.9.1 Johnson & Johnson Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Combined Hormonal Contraceptives
      • 10.9.4 Combined Hormonal Contraceptives Product Introduction
      • 10.9.5 Johnson & Johnson Recent Development
    • 10.10 Mylan
      • 10.10.1 Mylan Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Combined Hormonal Contraceptives
      • 10.10.4 Combined Hormonal Contraceptives Product Introduction
      • 10.10.5 Mylan Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Combined Hormonal Contraceptives Sales Channels
      • 11.2.2 Combined Hormonal Contraceptives Distributors
    • 11.3 Combined Hormonal Contraceptives Customers

    12 Market Forecast

    • 12.1 Global Combined Hormonal Contraceptives Sales and Revenue Forecast 2019-2025
    • 12.2 Global Combined Hormonal Contraceptives Sales Forecast by Type
    • 12.3 Global Combined Hormonal Contraceptives Sales Forecast by Application
    • 12.4 Combined Hormonal Contraceptives Forecast by Regions
      • 12.4.1 Global Combined Hormonal Contraceptives Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Combined Hormonal Contraceptives Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Combined Hormonal Contraceptives. Industry analysis & Market Report on Combined Hormonal Contraceptives is a syndicated market report, published as Global (United States, European Union and China) Combined Hormonal Contraceptives Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Combined Hormonal Contraceptives market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,581.36
      3,872.04
      5,162.72
      3,020.88
      4,531.32
      6,041.76
      511,942.40
      767,913.60
      1,023,884.80
      273,289.60
      409,934.40
      546,579.20
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report